INHIBITION OF P-GLYCOPROTEIN BY TREATMENT WITH A CLASS OF MODULATORS AND THE UIC2 MONOCLONAL ANTIBODY - Patent 1865987

(19)

(11)

EP 1 865 987 A2

(12)

(88)	Date of publication A3:
	11.01.2007

(43)	Date of publication:
	19.12.2007 Bulletin 2007/51

(21)	Application number: 06740584.5

(22)	Date of filing: 05.04.2006

(51)

International Patent Classification (IPC):

A61K 39/395^(2006.01)

(86)	International application number:
	PCT/US2006/012738

(87)	International publication number:
	WO 2006/108070 (12.10.2006 Gazette 2006/41)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30)

Priority:

06.04.2005 US 668846 P

(71)	Applicant: Cedars-Sinai Medical Center
	Los Angeles, California 90048 (US)

(72)	Inventors:
	SZABÓ, Gábor H-4033 Debrecen (HU) GODA, Katalin H-4031 Debrecen (HU)

(74)	Representative: Hutter, Anton et al
	AdamsonJones BioCity Nottingham Pennyfoot Street GB-Nottingham NG1 1GF GB-Nottingham NG1 1GF (GB)

(54)	INHIBITION OF P-GLYCOPROTEIN BY TREATMENT WITH A CLASS OF MODULATORS AND THE UIC2 MONOCLONAL ANTIBODY